Amy Tam, Ph.D.

Affiliations: 
Johns Hopkins University, Baltimore, MD 
Area:
s.cerevisiae, membrane biology, ABC transporters, protein degradation mechanisms
Google:
"Amy Tam"
Mean distance: 21373.2 (cluster 53)
 

Parents

Sign in to add mentor
Susan Michaelis grad student 2000 Johns Hopkins
 (Role of Ste24p in CaaX processing and N-terminal proteolysis of yeast a-factor.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Fung E, Kang L, Sapashnik D, et al. (2021) Fc-GDF15 glyco-engineering and receptor binding affinity optimization for body weight regulation. Scientific Reports. 11: 8921
Tevelev B, Patel H, Shields K, et al. (2021) Genetic Rearrangement During Site Specific Integration Event Facilitates Cell Line Development of a Bispecific Molecule. Biotechnology Progress. e3158
Root AR, Guntas G, Katragadda M, et al. (2021) Discovery and optimization of a novel anti-GUCY2c x CD3 bispecific antibody for the treatment of solid tumors. Mabs. 13: 1850395
Apgar JR, Tam ASP, Sorm R, et al. (2020) Modeling and mitigation of high-concentration antibody viscosity through structure-based computer-aided protein design. Plos One. 15: e0232713
Ngo KA, Kishimoto K, Davis-Turak J, et al. (2020) Dissecting the Regulatory Strategies of NF-κB RelA Target Genes in the Inflammatory Response Reveals Differential Transactivation Logics. Cell Reports. 30: 2758-2775.e6
Zhong X, Ma W, Meade CL, et al. (2018) A Transient CHO Expression Platform for Robust Antibody Production and Its Enhanced N-Glycan Sialylation on Therapeutic Glycoproteins. Biotechnology Progress
Weng Y, Ishino T, Sievers A, et al. (2018) Glyco-engineered Long Acting FGF21 Variant with Optimal Pharmaceutical and Pharmacokinetic Properties to Enable Weekly to Twice Monthly Subcutaneous Dosing. Scientific Reports. 8: 4241
Avery LB, Wade J, Wang M, et al. (2017) Establishing in vitro in vivo correlations to screen monoclonal antibodies for physicochemical properties related to favorable human pharmacokinetics. Mabs. 0
de Costa A, Tam A. (2017) Liability for providing a prognosis in surgical practice. The Medico-Legal Journal. 85: 145-147
Tumey LN, Li F, Rago B, et al. (2017) Site Selection: a Case Study in the Identification of Optimal Cysteine Engineered Antibody Drug Conjugates. The Aaps Journal
See more...